Literature DB >> 8898093

Evidence that Arg-295, Glu-378, and Glu-380 are active-site residues of the ADP-ribosyltransferase activity of iota toxin.

S Perelle1, M Domenighini, M R Popoff.   

Abstract

The active site of the enzymatic component (Ia) of the Clostridium perfringens iota toxin has been studied by site-directed mutagenesis. Sequence alignment showed that Ia and C3 enzymes display a segment in their C-terminal part which is homologous to that forming the active domain of pertussis toxin, cholera toxin, and Escherichia coli thermolabile toxins. This structure consists of a beta-strand and an alpha-helix which forms the NAD-binding cavity and which is flanked by two catalytic spatially conserved residues involved in catalysis [Domenighini et al. (1994) Mol. Microbiol. 14, 41-50]. Substitutions (Arg-295-Lys, Glu-378-Ala, Glu-380-Asp, and Glu-380-Ala) induced a drastic decrease in ADP-ribosylation and cytotoxic activities, while substitution of the adjacent Arg (Arg-296-Lys) only partially affected the enzymatic activity and cytotoxicity. These results indicate that Arg-295, Glu-378 and Glu-380 of Ia are involved in the ADP-ribosylation activity which is essential for the morphological changes of cells treated with iota toxin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898093     DOI: 10.1016/0014-5793(96)01035-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

1.  Clostridium perfringens iota-toxin: mapping of receptor binding and Ia docking domains on Ib.

Authors:  J C Marvaud; T Smith; M L Hale; M R Popoff; L A Smith; B G Stiles
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Characterization of the enzymatic component of Clostridium perfringens iota-toxin.

Authors:  M Nagahama; Y Sakaguchi; K Kobayashi; S Ochi; J Sakurai
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

3.  Pseudomonas aeruginosa exoenzyme S is a biglutamic acid ADP-ribosyltransferase.

Authors:  J Radke; K J Pederson; J T Barbieri
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Binding component of Clostridium perfringens iota-toxin induces endocytosis in Vero cells.

Authors:  Masahiro Nagahama; Koichi Nagayasu; Keiko Kobayashi; Jun Sakurai
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Clostridium perfringens iota-toxin requires activation of both binding and enzymatic components for cytopathic activity.

Authors:  M Gibert; L Petit; S Raffestin; A Okabe; M R Popoff
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

6.  Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile.

Authors:  I Gülke; G Pfeifer; J Liese; M Fritz; F Hofmann; K Aktories; H Barth
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90.

Authors:  Eva Kaiser; Claudia Kroll; Katharina Ernst; Carsten Schwan; Michel Popoff; Gunter Fischer; Johannes Buchner; Klaus Aktories; Holger Barth
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

8.  Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins.

Authors:  Sergey M Bezrukov; Xian Liu; Vladimir A Karginov; Alexander N Wein; Stephen H Leppla; Michel R Popoff; Holger Barth; Ekaterina M Nestorovich
Journal:  Biophys J       Date:  2012-09-19       Impact factor: 4.033

Review 9.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

10.  The long-lived nature of clostridium perfringens iota toxin in mammalian cells induces delayed apoptosis.

Authors:  Hanna Hilger; Sascha Pust; Guido von Figura; Eva Kaiser; Bradley G Stiles; Michel R Popoff; Holger Barth
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.